The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 57 (4) , 804-809
- https://doi.org/10.1016/s0015-0282(16)54962-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilizationFertility and Sterility, 1991
- Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatmentFertility and Sterility, 1990
- Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transferFertility and Sterility, 1990
- Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilizationFertility and Sterility, 1989
- Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrievalFertility and Sterility, 1989
- Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilizationFertility and Sterility, 1988
- Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormoneBMJ, 1988
- Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulationFertility and Sterility, 1988
- Two years’ experience of ultrasound-directed oocyte retrievalFertility and Sterility, 1987
- INDUCTION OF OVULATION FOR IN-VITRO FERTILISATION USING BUSERELIN AND GONADOTROPINSThe Lancet, 1984